Our Services

HTN helps investors, founders, and strategic partners reduce the cost, delay, and risk of being wrong about a healthcare innovation.

​

"We are here to help before you commit major capital, time, reputation or operational effort"   I. George, Founder CTO.

​

HTN offers healthcare innovation assessments and advisory support for founders, investors, strategics, and growth-stage companies.

​

Our work is designed to answer a practical question: is this innovation ready to move forward, and if not, what must be fixed before more time, capital, or credibility is spent?

​

We support clients across the innovation lifecycle, from early concept review and investor readiness to market launch, scale, partnership, and acquisition planning. Each engagement is built around the same core purpose: helping clients understand the real clinical, operational, commercial, regulatory, and adoption risks that determine whether a healthcare innovation can succeed.

​

HTN combines structured scoring, expert review, and access to experienced healthcare operators, clinicians, industry leaders, and business advisors. Our team helps clients pressure-test assumptions, clarify buyer pathways, identify adoption barriers, and determine what evidence or support may be needed next.

 

Depending on the engagement, HTN can help clients evaluate or prepare for:

• Early clinical feasibility

• First-in-human planning

• Hospital and IDN adoption strategy

• OEM and strategic partnership readiness

• Health economics and outcomes research planning

• Investor diligence and fundraising readiness

• Market entry and commercialization strategy

• Workflow, procurement, and implementation barriers

• Strategic positioning for scale, acquisition, or partnership

 

Our reports and advisory work are grounded in HTN’s internal assessment frameworks, including HIEF, MRA, SLEE, ARC, G-CAP, the Investor Readiness Matrix, Geo-Readiness, Runways, and Gates Analysis. Together, these tools allow HTN to assess more than 65 dimensions of innovation readiness across clinical value, market fit, evidence burden, buyer behavior, operational feasibility, strategic alignment, and adoption risk.

 

What sets HTN reports apart is not simply the use of AI, scoring, or templates. It is the combination of structured analysis and lived healthcare experience.

 

AI can summarize available information. HTN evaluates whether the right questions were asked, whether the assumptions are sound, and whether the opportunity makes sense in the real world of hospitals, clinicians, investors, payers, and strategic buyers.

 

HTN reports are modular, evidence-informed, and built for decision-making. They help clients see the strengths, gaps, friction points, and next steps that matter most. Final length and depth vary by engagement, but every report is designed to be clear, defensible, and useful to the people making decisions.